Leukemia research · 2002
High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Niitsu Nozomi, Iijima Kimiko
Аннотация
We measured soluble CD44 (sCD44) by enzyme-linked immunosorbent assay in 216 patients with non-Hodgkin's lymphoma (NHL). The sCD44 level was significantly elevated in patients with NHL. A sCD44 level of > or =500 ng/ml showed a significantly decreased overall survival (OS) rate and progression free survival (PFS) rate. In the high-intermediate+high risk group (international prognostic index (IPI)), both the OS rate and the PFS rate were significantly decreased when the sCD44 level was > or =1000 ng/ml. Moreover, the results of a multivariate analysis showed that the five IPI prognostic factors and the sCD44 level were independent prognostic factors, thus suggesting that sCD44 levels could be a useful prognostic marker for aggressive lymphoma
Предметные рубрики MeSH
AdultAgedAntigens, CDBiomarkers, TumorDisease ProgressionDisease-Free SurvivalFemaleHumansHyaluronan ReceptorsLymphoma, B-CellLymphoma, B-Cell, Marginal ZoneLymphoma, Non-HodgkinLymphoma, T-CellMaleMiddle AgedNeoplasm StagingPredictive Value of TestsPrognosisReference ValuesRetrospective StudiesSurvival RateTime Factors